Neumora Therapeutics NMRA
NASDAQ NMRA
$0.68 -0.01 (-2.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Total Liabilities (2022 - 2026)

Updated

Neumora Therapeutics (NMRA) reported Total Liabilities of $80.73 million for Q2 2026, up 97.2% from $40.95 million a year earlier but down 3.0% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Total Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Neumora Therapeutics posted Total Liabilities of $87.18 million, up 191.5% from FY2024.

  • Total Liabilities has a three-year compound annual growth rate of -53.6% (FY2022 to FY2025).
  • By year, Total Liabilities came in at $29.91 million in FY2024 (+10.3%), $27.12 million in FY2023 (-96.9%) and $873.08 million in FY2022.
  • Five-year quarterly Total Liabilities spans a low of $23.21 million in Q2 2024 and a high of $873.08 million in Q4 2022.
  • Year over year, Total Liabilities has now increased in each of the last seven quarters, with growth averaging 77.7% over the last eight quarters.
  • The high point for year-over-year Total Liabilities in five years was Q1 2026 (growth of 193.1%); the low point was Q4 2023 (a decline of 96.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $83.2 million (Q1 2026), $87.18 million (Q4 2025) and $45.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Neumora Therapeutics 129.65 Mn 129.65 Mn - 80.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.73 Mn
Mar 31, 2026 83.20 Mn
Dec 31, 2025 87.18 Mn
Sep 30, 2025 45.67 Mn
Jun 30, 2025 40.95 Mn
Mar 31, 2025 28.38 Mn
Dec 31, 2024 29.91 Mn
Sep 30, 2024 31.80 Mn
Jun 30, 2024 23.21 Mn
Mar 31, 2024 25.67 Mn
Dec 31, 2023 27.12 Mn
Sep 30, 2023 32.06 Mn
Dec 31, 2022 873.08 Mn
API Access

Neumora Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NMRA&period=max&api_key=YOUR_API_KEY